Zweig-DiMenna Associates’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-8,600
Closed -$311K 170
2017
Q3
$311K Buy
+8,600
New +$311K 0.03% 136